Description
Hardly reversible, non-competitive, and potent inhibitor of CPA1, CPA2 and CPA4. May play a role in inflammation.
A1417 | Anti-LXN Antibody DataSheet
Antibody Target: LXN
Target Alternative Name: Latexin; Endogenous carboxypeptidase inhibitor; ECI; Protein MUM; Tissue carboxypeptidase inhibitor; TCI
Tag Line: Polyclonal Antibody to detect LXN in human samples
Category: Immunology
Host: Rabbit
Isotype: Rabbit IgG
Species Reactivities: Human, Mouse and Rat
Immunogen Sequence: KLH-conjugated synthetic peptide encompassing a sequence within the center region of LXN
Accession #: Q9BS40
Gene ID: Q64361
Appearance: Colorless liquid
Form: Liquid
Concentration:
Formulation: In 0.42% Potassium phosphate; 0.87% Sodium chloride; pH 7.3; 30% glycerol and 0.01% sodium azide
Purification: Affinity purified
Application: WB, IHC
Positive Control: WB: 22RV1; MCF7; HT29; BT474; mouse heart whole cell lysates.
Application And Usages: WB; 1:500 1:2000, IHC; 1:50 1:200
Country of Animal Origin: USA
Country of Manufacture: USA
Usage: For Research Use Only! Not to be used in humans.
Handling: The antibody solution should be gently mixed before use.
Western Blot Verified: Verified
Immunocytochemistry Verified: Verified
Immunofluorescence Verified: Not Verified
Immunoprecipitation Verified: Not Verified
FACS Verified: Not Verified
ELISA Verified: Not Verified
ChIP Verified: Not Verified
Dot Blot Verified: Not Verified
Flow Cytometry Verified: Not Verified
Additional Information
Size: |
100 uL |
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
12 months |